Chloroquine therapy in patients with recent-onset rheumatoid arthritis: The clinical response can be predicted by the low level of acute-phase reaction at baseline

Clinical Rheumatology

Volumn 18, Issue 5, 1999, Pages 369-372

  Van Den Borne, B E E M ^a   Landewe R B M ^b   Rietveld, J H ^b   Goei The, H S ^b   Griep, E N ^b   Breedveld, F C ^b   Dijkmans, B A C ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Chloroquine; Clinical response; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CHLOROQUINE;

ADULT; AGED; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ACUTE-PHASE REACTION; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CHLOROQUINE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; TREATMENT OUTCOME;

EID: 0032833545     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050121     Document Type: Article

References (18)

1. Wilske KR, Healey LA. Challenging the therapeutic pyramid: a new look at treatment strategies for rheumatoid arthritis. J Rheumatol 1990;25(suppl):4-7.
2. Jaffe IA. New approaches to the management of rheumatoid arthritis. J Rheumatol 1992;19(suppl 36):2-8.
3. Emery P. Early rheumatoid arthritis: therapeutic strategies. Scand J Rheumatol 1994;100(suppl):3-7.
4. Kremer JM. The changing face of therapy for rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:845-52.
5. van Zeben D, Hazes JM, Zwinderman AH, Vandenbroucke JP, Breedveld FC. The severity of rheumatoid arthritis: a 6-year followup study of younger women with symptoms of recent onset. J Rheumatol 1994;21:1620-5.
6. van Zeben D, Hazes JM, Vandenbroucke JP, Dijkmans BA, Cats A. Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use. Arthritis Rheum 1990;33:1462-5.
7. Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy/ toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials. Arthritis Rheum 1992;35:1117-25.
8. Felson DT, Anderson JJ, Meenan RF. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum 1990;33:1449-61.
9. Nuver-Zwart IH, van Riel PL, van de Putte LB, Gribnau FW. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Ann Rheum Dis 1989;48:389-95.
10. Landewe RB, Goei The HS, van Rijthoven AW, Breedveld FC, Dijkmans BA. A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 1994;37:637-43.
11. Grosflam J, Weinblatt ME. Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity. Curr Opin Rheumatol 1991;3:363-8.
12. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
13. van den Borne BE, Landewé RB, Goei The HS, Rietveld JH, Zwinderman AH, Bruyn GA, et al. Combination therapy in recent onset rheumatoid arthritis: a randomized double-blind trial of the addition of low dose cyclosporine to patients with low dose chloroquine. J Rheumatol 1998;251493-8.
14. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:393-406.
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
16. Siegert CE, Vleming LJ, Vandenbroucke JP, Cats A. Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol 1984;3:305-9.
17. Masi AT, Maldonado-Cocco JA, Kaplan SB, Feigenbaum SL, Chandler RW. Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome. Semin Arthritis Rheum 1976;5299-325.
18. Eberhardt KB, Rydgren LC, Petterson H, Wollheim FA. Early rheumatoid arthritis - onset, course, and outcome over 2 years. Rheumatol Int 1990;10:135-42.